MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Detection and classification of GBA variants PD-related: is there sex unbalance?

    C. Reale, C. Panteghini, I. Colangelo, M. Suerz, R. Cilia, R. Eleopra, B. Garavaglia, F. Invernizzi (Milan, Italy)

    Objective: This study aims to classify GBA variants detected in the Genetic Movement Disorders Laboratory (GMDL) of the Neurological Institute “Carlo Besta” in Milan over…
  • 2023 International Congress

    Testing the applicability of the dysarthria analyzer to detect levodopa effects on speech in a German cohort of people with Parkinson’s disease

    T. Thies, J. Schreen, H. Jergas, M. Barbe (Cologne, Germany)

    Objective: To test the applicability of “the dysarthria analyzer” in a levodopa challenge test to determine short term effects of levodopa on acoustic speech parameters.…
  • 2023 International Congress

    Clinical and radiological gender differences in Parkinson’s disease

    G. Martí-Andrés, E. Prieto-Azcarate, CA. Espinoza-Vinces, M. Riverol, S. Meles, KL. Leenders, P. Tomse, M. Perovnik, M. Trost, J. Arbizu, MR. Luquin-Puido (Pamplona, Spain)

    Objective: To assess clinical and brain metabolic gender differences in a cohort of patients with PD Background: Many studies have elucidated gender-related clinical differences in…
  • 2023 International Congress

    Specific ethnicity could have different risk factors for Parkinson’s disease: a descriptive study

    S. Marisdina, S. Handayani, Y. Diansari, M. Odiesta (Palembang, Indonesia)

    Objective: The objective of this study was to determine if there were different risk and protective factors for Parkinson’s disease (PD) based on subethnicity in…
  • 2023 International Congress

    The role of structural changes in the retina and the vertical vestibulo-ocular reflex abnormality in gait disorders in Parkinson`s disease

    O. Alenikova, O. Davydova, N. Alenikov (Minsk, Belarus)

    Objective: Our goal was to investigate retinal structural changes as well as changes in visual cortex in PD patients with suppression deficiency of VOR and…
  • 2023 International Congress

    Development and Clinimetric Testing Plan for the MDS Parkinson’s Disease Psychosis Rating Scale (MDS-PDPRS)

    M. Tosin, T. Mestre, G. Stebbins, G. Mangone, S. Videmsky, S. Ali, D. Aarsland, J. Goldman, T. Khoo, S. Lewis, P. Martinez-Martin, O. Ojo, J. Pagonabarraga, A. Schrag, D. Weintraub, C. Goetz (Chicago, USA)

    Objective: Present the development process and clinimetric testing plan for the International Parkinson and Movement Disorder Society Parkinson's Disease Psychosis Rating Scale (MDS-PDPRS). Background: Psychosis…
  • 2023 International Congress

    A Novel Real Time Algorithm to Predict Freezing of Gait in Parkinson’s Patients Using Wearable Mobility Sensors Data

    N. Galor, T. Krasovsky, S. Hassin, B. Heimler, M. Plotnik (Ramat Gan, Israel)

    Objective: To develop an algorithm for real-time Freezing of gait (FOG) prediction based on the online monitoring of the stepping coherence. Background: FOG is a…
  • 2023 International Congress

    Keyboard tapping performance in people with subjective REM sleep behaviour disorder

    H. Chohan, C. Simonet, M. Periñán, L. Pérez-Carbonell, G. Leschziner, A. Gill, J. Bestwick, A. Schrag, A. Noyce (London, United Kingdom)

    Objective: The aim of this study was to compare the BRAIN test performance of people with subjective RBD (sRBD, defined by RBD screening questionnaire score >53)…
  • 2023 International Congress

    Short-term, intermittent exercise program improved the balance and gait in patients with Parkinson’s disease

    YC. Chein, JC. Hsu, KH. Chen, HY. Chen, CF. Lo, WE. Lee (Hsinchu City, Taiwan)

    Objective: To explore the effects of a short-term, intermittent exercise program combined dynamic movement and core muscle training on balance and gait in patients with…
  • 2023 International Congress

    Preliminary Report on the efficacy of Allogeneic Bone marrow-derived Mesenchymal Stem Cells as a disease-modifying therapy for idiopathic Parkinson’s disease: Phase IIa double-blind, randomized controlled trial.

    M. Schiess, J. Suescun, C. Green, E. Tharp, S. Chandra, C. Adams, M. Shahnawaz, E. Rodarte, V. Thyne, T. Ellmore (Houston, USA)

    Objective: To select the safest and most effective number of repeat doses of allogeneic mesenchymal stem cells (MSC) delivered intravenously to slow the progression of…
  • « Previous Page
  • 1
  • …
  • 40
  • 41
  • 42
  • 43
  • 44
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #23285 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley